Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 5, 1996, Pages 799-807

  Matera, G ^a   Berlinghieri, M C ^a   Foti, F ^a   Barreca, G S ^a   Foca A ^a  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CYTOKINE; FLEROXACIN; FLEROXACIN DEACETYLCEFOTAXIME ESTER; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL FUNCTION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; DOSE RESPONSE; HOST RESISTANCE; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL;

EID: 0029803606     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.5.799     Document Type: Article

References (24)

1. Bailly, S., Fay, M., Ferrua, B. & Gougerot-Pocidalo, M. A. (1991). Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumor necrosis factor-alpha. Clinical and Experimental Immunology 85, 331-4.
2. Bailly, S., Fay, M. & Gougerot-Pocidalo, M. A. (1993). Effets des antibiotiques sur la production de cytokines par les monocytes humains. Pathologie Biologie 41, 838-44.
3. Bailly, S., Mahe, Y., Ferrua, B., Fay, M., Tursz, T., Wakasugi, H. et al. (1990). Quinolone-induced differential modification of IL-1 alpha and IL-1 beta production by LPS-stimulated human monocytes. Cellular Immunology 128, 277-88.
4. Beskid, G., Fallat, V., Lipschitz, E. R., McGarry, D. H., Cleeland, R., Chan, K. et al. (1989). In vitro activities of dual-action antibacterial agents, Ro 23-9424, and comparative agents. Antimicrobial Agents and Chemotherapy 33, 1072-7.
5. Beskid, G., Siebelist, J., McGarry, C. M., Cleeland, R., Chan, K. & Keith, D. D. (1990). In vivo evaluation of a dual-action antibacterial, Ro 23-9424 compared to cefotaxime and fleroxacin. Chemotherapy 36, 109-16.
6. Boman, H. G. (1995). Peptide antibiotics and their role in innate immunity. Annual Review of Immunology 13, 61-92.
7. Focà, A., Liberto, M. C., Berlinghieri, M. C., Puccio, R. & Matera, G. (1991). Teicoplanin does not affect human granulocyte functions. Journal of Chemotherapy 4, Suppl 4, 548S-50.
8. Forsgren, A. & Bergkvist, P. I. (1985). Effect of ciprofloxacin on phagocytosis. European Journal of Clinical Microbiology 4, 575-8.
9. Gemmell, C. G. (1993). Antibiotics and neutrophil function - potential immunomodulating activities. Journal of Antimicrobial Chemotherapy 31, Suppl B, 23-33.
10. Georgopapadakou, N. H., Bertasso, A., Chan, K. K., Chapman, J. S., Cleeland, R., Cummings, L. M. et al. (1989). Mode of action of the dual-action cephalosporin Ro 23-9424. Antimicrobial Agents and Chemotherapy 33, 1067-71.
11. Gillissen, G. & Melzer, B. (1985). Influence of antibiotics on the production of interleukin-1 by macrophages. Pathologie Biologie 33, 521-4.
12. Glauser, M. P., Heumann, D., Baumgartner, J. D. & Cohen, J. (1994). Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clinical Infectious Diseases 18, Suppl 2, S205-16.
13. Johnston, R. B., Godzik, C. A. & Cohn, Z. A. (1978). Increased superoxide anion production by immunologically activated and chemically elicited macrophages. Journal of Experimental Medicine 148, 115-127.
14. Labro, M. T., Amit, N., Babin-Chevaye, C. & Hakim, J. (1987). Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity. Journal of Antimicrobial Chemotherapy 19, 331-41.
15. Labro, M. T., Babin-Chevaye, C. & Hakim, J. (1986). Effects of cefotaxime and cefodizime on human granulocyte functions in vitro. Journal of Antimicrobial Chemotherapy 18, 233-7.
16. Labro, M. T. & El Benna, J. (1991). Effects of anti-infectious agents on polymorphonuclear neutrophils. European Journal of Clinical Microbiology and Infectious Diseases 10, 124-31.
17. Maderazo, E. & Waronick, C. L. (1978). A modified micropore filter assay of human granulocytes chemotaxis. In Leukocyte Chemotaxis (Quie, P. G. & Galin, J. L., Eds) pp. 43-47. Raven Press, New York.
18. Matera, G., Berlinghieri, M. C. & Focà, A. (1995). Meropenem: effects on human leukocyte functions and interleukin release. International Journal of Antimicrobial Agents 5, 129-33.
19. Osaki, E., Anjo, S., Ishibashi, Y. & Arai, T. (1993). Cefodizime enhances formyl-methionyl-leucyl-phenilalanine-induced hydrogen peroxide production by human neutrophils. Journal of Antimicrobial Chemotherapy 32, 656-7.
20. Peman, J., Canton, E., Hernandez, M. T. & Gobernado, M. (1994). Intraphagocytic killing of gram-positive bacteria by ciprofloxacin. Journal of Antimicrobial Chemotherapy 34, 965-74.
21. Rolston, K. V. I., Nguyen, H. T., Ho, D. H., LeBlanc, B. & Bodey, G. P. (1992). In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents. Antimicrobial Agents and Chemotherapy 36, 879-82.
22. Shalit, I. (1991). Immunological aspects of new quinolones. European Journal of Clinical Microbiology and Infectious Diseases 10, 262-6.
23. Smith, D. L. & Rommel, F. J. (1977). Rapid micro method for the simultaneous determination of phagocytic-microbial activity of human peripheral blood leukocytes in vitro. Journal of Immunological Methods 17, 241-9.
24. van Rensburg, C. E. J., Joone, G. & Anderson, R. (1990). Interactions of oxygen-dependent antimicrobial system of the human neutrophil with difloxacin, ciprofloxacin, perfloxacin, and fleroxacin in the intraphagocytic eradication of Staphylococcus aureus. Journal of Medical Microbiology 32, 15-7.